Bio-Techne (TECH) Stock: Buy, Sell, or Hold?
TECH - Bio-Techne Corp.
$72.62
-0.02 (-0.03%)
▼
5d:
+0.14%
30d:
+0.14%
90d:
+1.42%
HOLD
MODERATE Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
11d
Get Alerted When TECH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TECH trades at premium valuation expecting 11.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: TECH trades at premium valuation expecting 11.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.06
Based on -6.4% avg growth
INTRINSIC VALUE TODAY
$18.67
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TECH is currently trading at $72.62, which is considered extended relative to its 30-day fair value range of $72.39 to $72.58. From a valuation perspective, the stock is trading at a premium (Forward PE: 42.7) compared to its historical average (31.1). At these levels, the market is pricing in 11.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $72.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $72.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$72.39 -
$72.58
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
46.2%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($70.50)
- NEUTRAL: PE elevated vs history but 11.1% growth expectation is conservative given 129% recent growth
- NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$72.39 -
$72.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$72.44
Resistance Level
$72.69
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
42.72
Wall Street Target
$70.50
(-2.9%)
Revenue Growth (YoY)
1.3%
Earnings Growth (YoY)
128.6%
Profit Margin
15.0%
Valuation Premium vs History
+11.1% premium
PE vs Historical
42.7 vs 31.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.1%
(market-implied from PE analysis)
1-Year Target
$80.68
(+11%)
2-Year Target
$89.64
(+23%)
3-Year Target
$99.59
(+37%)
3-Yr Target (if PE normalizes)
(PE: 43→31)
PE COMPRESSION
$72.50
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 42.7, Growth: -16.8%)
$52.94
(+-27%)
Base:
(SPY PE: 19.9, Growth: -16.8%)
$24.61
(-66%)
Bear:
(PE: 16.9, Growth: -16.8%)
$20.92
(-71%)
📈
Valuation based on Current Earnings
Forward PE: 34.60 | Forward EPS (Implied): $2.10
Bull Case
$87.69
(+21%)
Analyst growth 15.0%, PE expands to 36.3
Base Case
$72.62
(0%)
Market implied 0.0%, PE stable at 34.6
Bear Case
$55.55
(-24%)
Severe decline -15.0%, PE contracts to 31.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 9:08 PM ET
Data refreshes hourly during market hours. Next update: 10:08 PM
Data refreshes hourly during market hours. Next update: 10:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TECH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 66 BUY |
